v3.26.1
Segment Reporting - Schedule of Consolidated Statements of Operations (Details) - Other Operating Segment [Member] - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Schedule of Consolidated Statements of Operations [Line Items]    
Salaries and related expenses, other than share-based compensation $ 1,773 $ 1,977
Clinical trials 95 3,626
Stock based compensation (1,928) 659
Depreciation expenses 236
Insurance 843  
Other segment items [1] 513 1,258
Total Operating expenses $ 1,296 $ 7,756
[1] Other segment items include all remaining costs necessary to operate the Company’s business, which primarily include external professional services, rent, insurance and other administrative expenses, and are presented net of grants received